Affiliation: Sunnybrook Health Sciences Centre
- Influenza virus emitted by naturally-infected hosts in a healthcare settingSamira Mubareka
Sunnybrook Research Institute, 2075 Bayview Avenue suite B103, Toronto, ON M4N 3M1, Canada Electronic address
J Clin Virol 73:105-7. 2015....
- Western Cold and Flu (WeCoF) aerosol study--preliminary resultsEric Savory
Department of Mechanical and Materials Engineering, The University of Western Ontario, 1151 Richmond Street North, London N6A 5B9, Canada
BMC Res Notes 7:563. 2014..The WeCoF project aims at providing evidence to support prevention measures to mitigate person-to-person influenza transmission in critical locations, such as hospitals, and during pandemics...
- Co-circulation of multiple genotypes of human rhinovirus during a large outbreak of respiratory illness in a veterans' long-term care homeSamira Mubareka
Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Suite B103, Toronto, ON M4N 3M5, Canada Electronic address
J Clin Virol 58:455-60. 2013..Human rhinoviruses (HRVs) are a well-recognized cause of long-term care home (LTCH) outbreaks of respiratory illness. However, there are limited data on the molecular epidemiology of the HRV types involved...
- Famciclovir: a focus on efficacy and safetySamira Mubareka
Sunnybrook Health Sciences Centre and Research Institute, Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON, M4N 3M5, Canada
Expert Opin Drug Saf 9:643-58. 2010..It is indicated for management of mucocutaneous herpes simplex virus disease and acute herpes zoster, and has been investigated for management of hepatitis B virus infection...
- Use of an improved quantitative polymerase chain reaction assay to determine differences in human rhinovirus viral loads in different populationsAndrea Granados
St Joseph s Healthcare, Hamilton, ON, Canada
Diagn Microbiol Infect Dis 74:384-7. 2012..001). Using an HRV qPCR, we showed that viral loads did not differ between the community and hospitalized populations and significantly decreased following symptoms onset in healthy individuals...
- Mesenchymal stromal (stem) cell therapy fails to improve outcomes in experimental severe influenzaIlyse Darwish
Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
PLoS ONE 8:e71761. 2013..We hypothesized that MSC therapy would improve survival, dampen lung inflammation and decrease acute lung injury (ALI) in a murine model of severe influenza...
- Immunomodulatory therapy for severe influenzaIlyse Darwish
Faculty of Medicine, Institute of Medical Science, McLaughlin Rotman Centre for Global Health, University Health Network, University of Toronto, Toronto, ON, Canada
Expert Rev Anti Infect Ther 9:807-22. 2011..We then conclude with a rationale for the use of mesenchymal stromal (stem) cells and angiopoietin-1 therapy against deleterious influenza-induced host responses that mediate end-organ injury and dysfunction...